Daisuke Usui
Vermögen: 213 932 $ am 31.05.2026
Vermögen: 213 932 $ am 31.05.2026
Daisuke Usui currently works at ReproCELL, Inc., as Chief Operating Officer & Director from 2020, RC Partners, Inc., as Director from 2016, ReproCELL Europe Ltd., as Director from 2016, and MAGiQ Therapeutics KK, as Director from 2019.
Mr. Usui also formerly worked at Reinnervate Ltd., as Chief Executive Officer.
Mr. Usui received his undergraduate degree from the University of Tsukuba.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPROCELL INC. 0,28 % | 31.03.2025 | 264 000 ( 0,28 % ) | 213 932 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| REPROCELL INCORPORATED | Geschäftsführer | 11.11.2020 |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance Engages in the operation and management of investment funds | Direktor/Vorstandsmitglied | 01.06.2016 |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a human tissue research facility | Direktor/Vorstandsmitglied | 01.07.2016 |
MAGiQ Therapeutics KK
MAGiQ Therapeutics KK Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Direktor/Vorstandsmitglied | 01.12.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Operates as a life sciences company which manufactures and distributes three dimensional cell culture products | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
University of Tsukuba
University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Operates as a life sciences company which manufactures and distributes three dimensional cell culture products | Health Technology |
ReproCELL, Inc.
ReproCELL, Inc. Medical SpecialtiesHealth Technology Engages in the reagents for ES/iPS and stem cell-derived functional cells | Health Technology |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance Engages in the operation and management of investment funds | Finance |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a human tissue research facility | Commercial Services |
MAGiQ Therapeutics KK
MAGiQ Therapeutics KK Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen